People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Anavex Life Sciences Corp. | — | Biotechnology | Series A | $10.5M | $361.5M | 2010 |
| IGXBio, Inc. | — | Biotechnology | Pre-Seed | $1.0M | $1.3M | — |
David Tousley at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Tousley on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Cameron Durrant | 1 | 5 |
| Harvey Lalach | 1 | 3 |
| Alison Ayers | 1 | 1 |
| Ed Stratemeier | 1 | 1 |
| Bill Garner | 1 | 1 |
| Ed Connolly, Jr. | 1 | 1 |
| Christopher U. Missling | 1 | 1 |
| James Laufenberg | 1 | 1 |
| Athanosios U. Skarpelos | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.